Naloxone HCl Dihydrate

CAS No. 51481-60-8

Naloxone HCl Dihydrate( Naloxone Hydrochloride Dihydrate | Naloxone HCl Dihydrate )

Catalog No. M18701 CAS No. 51481-60-8

Naloxone HCl Dihydrate is an opioid inverse agonist drug used to counter the effects of opiate overdose.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 Get Quote
200MG 59 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Naloxone HCl Dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Naloxone HCl Dihydrate is an opioid inverse agonist drug used to counter the effects of opiate overdose.
  • Description
    Naloxone HCl Dihydrate is a specific opiate antagonist. It acts by being competitive at mu, delta, and kappa opioid receptors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Naloxone Hydrochloride Dihydrate | Naloxone HCl Dihydrate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Opioid receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    51481-60-8
  • Formula Weight
    399.87
  • Molecular Formula
    C19H26ClNO6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O.O.Cl.OC1=C2O[C@H]3C(=O)CC[C@@]4(O)[C@H]5CC(C=C1)=C2[C@@]34CCN5CC=C
  • Chemical Name
    (4R,4aS,7aS,12bS)-3-allyl-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one hydrochloride dihydrate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Miglustat

    Miglustat is an alkylated product of imino sugar deoxynojirimycin.It?is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

  • Concizumab

    Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease inhibitor (KPI) 2 domain of TFPI, blocking its interaction with the FXa active site.

  • Chlorobenzothiazolin...

    Inhibition of recombinant human chymase using bis(succinoyl-L-alanyl-L-prolyl-L-phenylalanylamide) as substrate after 1 hr by fluorescence assay with activity value of 90μM